Recruiting

Observational Study

Sponsor:

NYU Langone Health

Code:

NCT03293758

Conditions

Cancer

Cardiovascular Diseases

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease

Conditions

Cancer

Cardiovascular Diseases

Study ID

NCT03293758

Start date

May 16, 2016

Status verified date

Feb, 2026

Completion date

Dec 31, 2034

Anticipated

Primary completion date

Dec 31, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Age > 40

Exclusion Criteria:

  • Use of long term antibiotics.
  • Pregnant

Study Design

Enrollment

16000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Demographic [ Time Frame: 5 Years ]

Central Contacts and Locations

Locations

New York University School of Medicine

Recruiting

New York, New York, United States, 10016

Contacts

Principal Investigator:

Jiyoung Ahn, PhD

More Information

Sponsor

NYU Langone Health

Last update posted

Feb 25, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2026-02-25.